-
Shire Development LLC et al v. Watson Pharmaceuticals, Inc. et al DC CAFC
- 0:12-cv-60862
- S.D. Fla.
- Judge: Donald M. Middlebrooks +1
- Filed: 05/08/2012
- Closed: 03/28/2016
- Latest Docket Entry: 05/19/2017
- PACER
- Docket updated daily
4
Plaintiffs
4
Defendants
1
Accused
Product
1
Patent-in-Suit
1,421
Days in
Litigation
-
Shire Development LLC et al v. Watson Pharmaceuticals, Inc. et al DC CAFC
- 0:12-cv-60862
- S.D. Fla.
- Judge: Donald M. Middlebrooks +1
- Filed: 05/08/2012
- Closed: 03/28/2016
- Latest Docket Entry: 05/19/2017
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
Controlled-release oral pharmaceutical compositions containing as an active ingredient 5-amino-salicylic acid, comprising:</claim-text> a) an inner lipophilic matrix consisting of substances selected from the group consisting of unsaturated and/or
view more
|
Valid (112)
Entry 246 |
3 |
Compositions as claimed in claim 1, in the form of tablets, capsules, mintablets.
|
Valid (112)
Entry 246 |
-
Infringement
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
1.2g Mesalamine delayed release tablet1.2 g of mesalamine delayed-release tabletsAbbreviated New Drug Application CSANDA No. 203817Generic1.2 g mesalnmine delayed-release tablet | US 6,773,720 B1 |
1, 3
|
Infringement
Entry 370Entry 359 Entry 247 Entry 246 |
Watson Pharmaceuticals, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
1.2g Mesalamine delayed release tablet1.2 g of mesalamine delayed-release tabletsAbbreviated New Drug Application CSANDA No. 203817Generic1.2 g mesalnmine delayed-release tablet | US 6,773,720 B1 |
1, 3
|
Infringement
Entry 370Entry 359 Entry 247 Entry 246 |
Watson Pharma, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
1.2 g of mesalamine delayed-release tabletsAbbreviated New Drug Application CSANDA No. 203817Generic1.2 g mesalnmine delayed-release tablet | US 6,773,720 B1 |
1, 3
|
Infringement
Entry 370Entry 359 Entry 246 |